Hyman BT - Search Results

1

Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease.

Donovan NJ, Amariglio RE, Zoller AS, Rudel RK, Gomez-Isla T, Blacker D, Hyman BT, Locascio JJ, Johnson KA, Sperling RA, Marshall GA, Rentz DM. Donovan NJ, et al. Among authors: hyman bt. Am J Geriatr Psychiatry. 2014 Dec;22(12):1642-51. doi: 10.1016/j.jagp.2014.02.007. Epub 2014 Feb 26. Am J Geriatr Psychiatry. 2014. PMID: 24698445 Free PMC article.

2

Quantitative assessment of ALZ-50 immunoreactivity in Alzheimer's disease.

Hyman BT, Flory JE, Arnold SE, Van Hoesen GW, Schelper RL, Ghanbari H, Haigler H. Hyman BT, et al. J Geriatr Psychiatry Neurol. 1991 Oct-Dec;4(4):231-5. doi: 10.1177/089198879100400410. J Geriatr Psychiatry Neurol. 1991. PMID: 1789912

3

Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy.

Greenberg SM, Rebeck GW, Vonsattel JP, Gomez-Isla T, Hyman BT. Greenberg SM, et al. Among authors: hyman bt. Ann Neurol. 1995 Aug;38(2):254-9. doi: 10.1002/ana.410380219. Ann Neurol. 1995. PMID: 7654074

4

Alzheimer's disease is a laminar, regional, and neural system specific disease, not a global brain disease.

Hyman BT, Gomez-Isla T. Hyman BT, et al. Neurobiol Aging. 1994 May-Jun;15(3):353-4; discussion 379-80. doi: 10.1016/0197-4580(94)90031-0. Neurobiol Aging. 1994. PMID: 7936060 No abstract available.

5

Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease.

Gomez-Isla T, West HL, Rebeck GW, Harr SD, Growdon JH, Locascio JJ, Perls TT, Lipsitz LA, Hyman BT. Gomez-Isla T, et al. Among authors: hyman bt. Ann Neurol. 1996 Jan;39(1):62-70. doi: 10.1002/ana.410390110. Ann Neurol. 1996. PMID: 8572669

6

Clinical and neuropathological correlates of apolipoprotein E genotype in Alzheimer's disease. Window on molecular epidemiology.

Hyman BT, Gomez-Isla T, West H, Briggs M, Chung H, Growdon JH, Rebeck GW. Hyman BT, et al. Ann N Y Acad Sci. 1996 Jan 17;777:158-65. doi: 10.1111/j.1749-6632.1996.tb34414.x. Ann N Y Acad Sci. 1996. PMID: 8624079 Review.

7

Apolipoprotein E and cognitive change in an elderly population.

Hyman BT, Gomez-Isla T, Briggs M, Chung H, Nichols S, Kohout F, Wallace R. Hyman BT, et al. Ann Neurol. 1996 Jul;40(1):55-66. doi: 10.1002/ana.410400111. Ann Neurol. 1996. PMID: 8687193

8

Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease.

Gómez-Isla T, Price JL, McKeel DW Jr, Morris JC, Growdon JH, Hyman BT. Gómez-Isla T, et al. Among authors: hyman bt. J Neurosci. 1996 Jul 15;16(14):4491-500. doi: 10.1523/JNEUROSCI.16-14-04491.1996. J Neurosci. 1996. PMID: 8699259 Free PMC article.

9

A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with the epsilon 4 allele.

Mui S, Briggs M, Chung H, Wallace RB, Gomez-Isla T, Rebeck GW, Hyman BT. Mui S, et al. Among authors: hyman bt. Neurology. 1996 Jul;47(1):196-201. doi: 10.1212/wnl.47.1.196. Neurology. 1996. PMID: 8710077

10

Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease.

Growdon JH, Locascio JJ, Corkin S, Gomez-Isla T, Hyman BT. Growdon JH, et al. Among authors: hyman bt. Neurology. 1996 Aug;47(2):444-8. doi: 10.1212/wnl.47.2.444. Neurology. 1996. PMID: 8757018

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

854 results

Search Page

Filters